SLNO241220P45000
- 0.20
- -2.35-92.16%
Soleno Therapeutics Newsroom
Soleno Therapeutics Analyst Ratings
H.C. Wainwright Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $70
Positive Outlook for Soleno Therapeutics: Buy Rating Based on Anticipated FDA Approval and Strong Cash Position
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $74
Soleno Therapeutics (SLNO) Receives a Buy From Stifel Nicolaus
Cantor Fitzgerald Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $67
Cantor Fitzgerald Remains a Buy on Soleno Therapeutics (SLNO)
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Soleno Therapeutics Is Maintained at Outperform by Oppenheimer
Soleno Therapeutics Analyst Ratings
Oppenheimer Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $73
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $74
A Quick Look at Today's Ratings for Soleno Therapeutics(SLNO.US), With a Forecast Between $65 to $75
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $74
Soleno Therapeutics Is Maintained at Buy by Stifel
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $74
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Piper Sandler Reaffirms Their Buy Rating on Soleno Therapeutics (SLNO)
Soleno Therapeutics Analyst Ratings